Login / Signup

End-Of-Life Care in the Potential Donor after Circulatory Death: A Systematic Review.

Stefanie P CappucciWade S SmithRichard SchwartzsteinDouglas B WhiteSusan L MitchellCorey R Fehnel
Published in: The Neurohospitalist (2022)
There is a paucity of empirical evidence for end-of-life symptom assessment and management for DCD patients. Key evidence gaps identified for DCD include the need for: i) a multidisciplinary structure of treatment teams and preferred environment for DCD, ii) objective tools for monitoring of distress in this patient population, and iii) evidence guiding the administration of analgesic medications following withdrawal of life sustaining therapy.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • chronic kidney disease
  • case report
  • prognostic factors
  • mesenchymal stem cells
  • bone marrow
  • patient reported outcomes
  • combination therapy